Continuous Lenalidomide Plus Dexamethasone FIRST in MyelomaContinuous Lenalidomide Plus Dexamethasone FIRST in Myeloma

For older multiple myeloma patients ineligible for transplantation, interim results from the FIRST trial suggest that continuous lenalidomide and dexamethasone is better than the standard of care. Medscape Medical News
Source: Medscape Hematology-Oncology Headlines - Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news